Michael Zand – Page 552

Stem cell transplants bring new hope for lung patients – The Indian Express

2018-02-10 Michael Zand NEWS

PARP Combos With Bevacizumab, Immunotherapy in Development for Ovarian Cancer Treatment – OncLive

OncLivePARP Combos With Bevacizumab, Immunotherapy in Development for Ovarian Cancer TreatmentOncLiveThe way forward for the treatment of patients with ovarian cancer will be with novel combination regimens, according to Rebecca C. Arend, MD. For examp… Continue reading

2018-02-10 Michael Zand NEWS

Stem cell donors needed for this Newcastle toddler with rare blood disease – ChronicleLive

ChronicleLiveStem cell donors needed for this Newcastle toddler with rare blood diseaseChronicleLiveStem cell donors needed for this Newcastle toddler with rare blood disease. Two-year-old Jacob Armstrong was diagnosed with aplastic anaemia after his p… Continue reading

2018-02-10 Michael Zand NEWS

Stem cell transplant offers long-term hope for severe scleroderma patients – ModernMedicine

Stem cell transplant offers long-term hope for severe scleroderma patientsModernMedicineAn intensive stem cell transplant regimen achieved better event-free survival and overall survival compared to cyclophosphamide drug treatment for patients with sev… Continue reading

2018-02-10 Michael Zand NEWS

Editas Medicine (EDIT) vs. PAREXEL International (PRXL) Financial Contrast – The Lincolnian Online

The Lincolnian OnlineEditas Medicine (EDIT) vs. PAREXEL International (PRXL) Financial ContrastThe Lincolnian OnlineIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. … Continue reading

2018-02-10 Michael Zand NEWS

Editas Medicine (EDIT) vs. PAREXEL International (PRXL) Financial Contrast – The Lincolnian Online

2018-02-10 Michael Zand NEWS

Contrasting Editas Medicine (EDIT) and Arena Pharmaceuticals (ARNA) – Dispatch Tribunal

BZ WeeklyContrasting Editas Medicine (EDIT) and Arena Pharmaceuticals (ARNA)Dispatch TribunalIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribon… Continue reading

2018-02-10 Michael Zand NEWS

1
…
550
551
552
553
554
…
3,823

The Indian Express

Stem cell transplants bring new hope for lung patients
The Indian Express
Chinese scientists, in a breakthrough, have regenerated a patient’s damaged lungs using stem cell transplants, a development that can lead to treatments for chronic lung diseases. In a pilot clinical trial for the transplantation, the scientists from …

and more »

Login

Cart

All posts by: Michael Zand

New immunotherapy combination tolerable, effective in patients with advanced kidney cancer – EurekAlert (press release)

Stem cell transplants bring new hope for lung patients – The Indian Express

PARP Combos With Bevacizumab, Immunotherapy in Development for Ovarian Cancer Treatment – OncLive

Stem cell donors needed for this Newcastle toddler with rare blood disease – ChronicleLive

Stem cell transplant offers long-term hope for severe scleroderma patients – ModernMedicine

Editas Medicine (EDIT) vs. PAREXEL International (PRXL) Financial Contrast – The Lincolnian Online

Editas Medicine (EDIT) vs. PAREXEL International (PRXL) Financial Contrast – The Lincolnian Online

Contrasting Editas Medicine (EDIT) and Arena Pharmaceuticals (ARNA) – Dispatch Tribunal